0001377053-14-000003.txt : 20140916 0001377053-14-000003.hdr.sgml : 20140916 20140916121256 ACCESSION NUMBER: 0001377053-14-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20140916 DATE AS OF CHANGE: 20140916 EFFECTIVENESS DATE: 20140916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AtheroNova Inc. CENTRAL INDEX KEY: 0001377053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201915083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-224793 FILM NUMBER: 141104907 BUSINESS ADDRESS: STREET 1: 2301 DUPONT DRIVE, SUITE 525 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: (949) 525-5471 MAIL ADDRESS: STREET 1: 2301 DUPONT DRIVE, SUITE 525 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: AtheroNova, Inc. DATE OF NAME CHANGE: 20100519 FORMER COMPANY: FORMER CONFORMED NAME: Trist Holdings, Inc. DATE OF NAME CHANGE: 20080103 FORMER COMPANY: FORMER CONFORMED NAME: LandBank Group Inc DATE OF NAME CHANGE: 20061002 D 1 primary_doc.xml X0707 D LIVE 0001377053 AtheroNova Inc. 2301 DUPONT DRIVE, SUITE 525 IRVINE CA CALIFORNIA 92612 (949) 525-5471 DELAWARE AtheroNova, Inc. Trist Holdings, Inc. LandBank Group Inc Corporation true Mark Selawski 2301 Dupont Drive, Suite 525 Irvine CA CALIFORNIA 92612 Executive Officer Thomas W Gardner 2301 Dupont Drive, Suite 525 Irvine CA CALIFORNIA 92612 Executive Officer Director Gary Freeman 2301 Dupont Drive, Suite 525 Irvine CA CALIFORNIA 92612 Director Paul DiPerna 2301 Dupont Drive, Suite 525 Irvine CA CALIFORNIA 92612 Director Boris Ratiner 2301 Dupont Drive, Suite 525 Irvine CA CALIFORNIA 92612 Director Chaim Davis 2301 Dupont Drive, Suite 525 Irvine CA CALIFORNIA 92612 Director Alexander Polinsky 2301 Dupont Drive, Suite 525 Irvine CA CALIFORNIA 92612 Director Fred Knoll 2301 Dupont Drive, Suite 525 Irvine CA CALIFORNIA 92612 Director Johan M Spoor 2301 Dupont Drive, Suite 525 Irvine CA CALIFORNIA 92612 Director Pharmaceuticals Decline to Disclose 06c false 2014-09-12 false true true true false 0 1000000 500000 500000 false 7 0 0 0 false AtheroNova Inc. /s/ Mark Selawski Mark Selawski Chief Financial Officer 2014-09-16